Cormark Has Negative Forecast for STERIS’ FY2024 Earnings

STERIS’ (TSE:STEFree Report) – Research analysts at Cormark cut their FY2024 earnings per share estimates for STERIS’ in a research note issued on Monday, November 18th. Cormark analyst B. Watson now anticipates that the company will post earnings per share of $0.25 for the year, down from their previous estimate of $0.77.

STERIS’ Stock Performance

About STERIS’

(Get Free Report)

STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.

Further Reading

Earnings History and Estimates for STERIS’ (TSE:STE)

Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.